OC2 suppression may serve as well to inhibit the emergence of basal-like features arising from phenotypic plasticity and loss of lineage confinement in BC tumors, where it could improve treatment outcomes solo or in combination with other known cancer drugs. Here, ONECUT2 is linked to cancer.